2022
DOI: 10.1016/j.ajur.2022.06.001
|View full text |Cite
|
Sign up to set email alerts
|

Small renal masses in kidney transplantation: Overview of clinical impact and management in donors and recipients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 71 publications
0
1
0
Order By: Relevance
“…Renal transplantation is considered to be the best treatment for end-stage renal disease, which greatly improves the quality of life and prognosis of patients. However, due to the influence of the long-term use of immunosuppressive agents on the human immune system, renal transplantation recipients are more prone to malignant tumors ( 1 ). Renal cell carcinoma (RCC) is the third most common malignancy in renal transplant recipients after cutaneous tumors and hematopoietic cell diseases ( 2 ).…”
Section: Introductionmentioning
confidence: 99%
“…Renal transplantation is considered to be the best treatment for end-stage renal disease, which greatly improves the quality of life and prognosis of patients. However, due to the influence of the long-term use of immunosuppressive agents on the human immune system, renal transplantation recipients are more prone to malignant tumors ( 1 ). Renal cell carcinoma (RCC) is the third most common malignancy in renal transplant recipients after cutaneous tumors and hematopoietic cell diseases ( 2 ).…”
Section: Introductionmentioning
confidence: 99%